De novo design of nonpeptidic HIV-1 protease inhibitors: Incorporation of structural water.
暂无分享,去创建一个
John W. Erickson | Stanley K. Burt | S. Gulnik | J. Erickson | S. Burt | Wenxi Pan | Ramnarayan S. Randad | Sergei V. Gulnik | R. Randad | Wenxi Pan
[1] Herbert M. Pickett,et al. Conformational structure, energy, and inversion rates of cyclohexane and some related oxanes , 1970 .
[2] Norman L. Allinger,et al. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms , 1977 .
[3] C. Knobler,et al. Host-guest complexation. 32. Spherands composed of cyclic urea and anisyl units , 1984 .
[4] S. Vasavanonda,et al. Structure-based, C2 symmetric inhibitors of HIV protease. , 1990, Journal of medicinal chemistry.
[5] D. Norbeck,et al. Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.
[6] PatrickY.-S. Lam,et al. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.